[1] 胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.
[2] HORNUNG S, DUTTA S, BITAN G. CNS-Derived Blood Exosomes as a Promising Source of Biomarkers: Opportunities and Challenges. Front Mol Neurosci. 2020;13:38.
[3] PHAM TP, BOON RA. Exosomes and non-coding RNA, the healers of the heart? Cardiovasc Res. 2020;116(2):258-259.
[4] TRAMS EG, LAUTER CJ, SALEM N JR, et al. Exfoliation of membrane ecto-enzymes in the form of micro-vesicles. Biochim Biophys Acta. 1981;645(1):63-70.
[5] PAN BT, JOHNSTONE RM. Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: selective externalization of the receptor. Cell. 1983;33(3):967-978.
[6] VAN NIEL G, D’ANGELO G, RAPOSO G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213-228.
[7] JOHNSTONE RM, ADAM M, HAMMOND JR, et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). J Biol Chem. 1987;262(19): 9412-9420.
[8] JOHNSTONE RM, BIANCHINI A, TENG K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood. 1989;74(5):1844-1851.
[9] ZITVOGEL L, REGNAULT A, LOZIER A, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4(5):594-600.
[10] SCHROEDER JC, PUNTIGAM L, HOFMANN L, et al. Circulating Exosomes Inhibit B Cell Proliferation and Activity. Cancers (Basel). 2020;12(8): 2110.
[11] SUN P, WANG N, ZHAO P, et al. Circulating Exosomes Control CD4+ T Cell Immunometabolic Functions via the Transfer of miR-142 as a Novel Mediator in Myocarditis. Mol Ther. 2020;28(12):2605-2620.
[12] SKOKOS D, LE PANSE S, VILLA I, et al. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol. 2001;166(2):868-876.
[13] LEMA DA, BURLINGHAM WJ. Role of exosomes in tumour and transplant immune regulation. Scand J Immunol. 2019;90(5):e12807.
[14] XU H, WANG Z, LIU L, et al. Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction. J Cell Biochem. 2020;121(3):2089-2102.
[15] LING X, ZHANG G, XIA Y, et al. Exosomes from human urine-derived stem cells enhanced neurogenesis via miR-26a/HDAC6 axis after ischaemic stroke. J Cell Mol Med. 2020;24(1):640-654.
[16] BERETTI F, ZAVATTI M, CASCIARO F, et al. Amniotic fluid stem cell exosomes: Therapeutic perspective. Biofactors. 2018;44(2):158-167.
[17] WEI M, YANG T, CHEN X, et al. Malignant ascites-derived exosomes promote proliferation and induce carcinoma-associated fibroblasts transition in peritoneal mesothelial cells. Oncotarget. 2017;8(26):42262-42271.
[18] PRADO N, MARAZUELA EG, SEGURA E, et al. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J Immunol. 2008;181(2):1519-1525.
[19] LÄSSER C, ALIKHANI VS, EKSTRÖM K, et al. Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med. 2011;9:9.
[20] SIMPSON RJ, JENSEN SS, LIM JW. Proteomic profiling of exosomes: current perspectives. Proteomics. 2008;8(19):4083-4099.
[21] RAPOSO G, NIJMAN HW, STOORVOGEL W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med. 1996;183(3):1161-1172.
[22] OTERO-ORTEGA L, LASO-GARCÍA F, GÓMEZ-DE FRUTOS M, et al. Role of Exosomes as a Treatment and Potential Biomarker for Stroke. Transl Stroke Res. 2019;10(3):241-249.
[23] HWANG I. Cell-cell communication via extracellular membrane vesicles and its role in the immune response. Mol Cells. 2013;36(2):105-111.
[24] TAYLOR DD, GERCEL-TAYLOR C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13-21.
[25] VALADI H, EKSTRÖM K, BOSSIOS A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9(6):654-659.
[26] MENASCHÉ P. Stem cell-derived exosomes and the failing heart: Small cause, big effect. J Thorac Cardiovasc Surg. 2018;156(3):1089-1092.
[27] HUANG X, YUAN T, LIANG M, et al. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2015;67(1):33-41.
[28] LAZAR E, BENEDEK T, KORODI S, et al. Stem cell-derived exosomes - an emerging tool for myocardial regeneration. World J Stem Cells. 2018;10(8):106-115.
[29] D’ALESSANDRA Y, DEVANNA P, LIMANA F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31(22):2765-2773.
[30] MATSUMOTO S, SAKATA Y, SUNA S, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113(3):322-326.
[31] DIVAKARAN V, MANN DL. The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res. 2008;103(10):1072-1083.
[32] HALKEIN J, TABRUYN SP, RICKE-HOCH M, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. 2013;123(5):2143-2154.
[33] RIBEIRO-RODRIGUES TM, LAUNDOS TL, PEREIRA-CARVALHO R, et al. Exosomes secreted by cardiomyocytes subjected to ischaemia promote cardiac angiogenesis. Cardiovasc Res. 2017;113(11):1338-1350.
[34] GUPTA S, KNOWLTON AA. HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. Am J Physiol Heart Circ Physiol. 2007; 292(6):H3052-3056.
[35] MALIK ZA, KOTT KS, POE AJ, et al. Cardiac myocyte exosomes: stability, HSP60, and proteomics. Am J Physiol Heart Circ Physiol. 2013;304(7): H954-965.
[36] CAMBIER L, GIANI JF, LIU W, et al. Angiotensin II-Induced End-Organ Damage in Mice Is Attenuated by Human Exosomes and by an Exosomal Y RNA Fragment. Hypertension. 2018;72(2):370-380.
[37] DAI Y, WANG S, CHANG S, et al. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway. J Mol Cell Cardiol. 2020;142:65-79.
[38] VAN BALKOM BW, DE JONG OG, SMITS M, et al. Endothelial cells require miR-214 to secrete exosomes that suppress senescence and induce angiogenesis in human and mouse endothelial cells. Blood. 2013;121(19):3997-4006.
[39] ZHAN R, LENG X, LIU X, et al. Heat shock protein 70 is secreted from endothelial cells by a non-classical pathway involving exosomes. Biochem Biophys Res Commun. 2009;387(2):229-233.
[40] PAONE S, BAXTER AA, HULETT MD, et al. Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis. Cell Mol Life Sci. 2019;76(6):1093-1106.
[41] YUE Y, WANG C, BENEDICT C, et al. Interleukin-10 Deficiency Alters Endothelial Progenitor Cell-Derived Exosome Reparative Effect on Myocardial Repair via Integrin-Linked Kinase Enrichment. Circ Res. 2020;126(3):315-329.
[42] BROSENS I, BENAGIANO M, PUTTEMANS P, et al. The placental bed vascular pathology revisited: a risk indicator for cardiovascular disease. J Matern Fetal Neonatal Med. 2019;32(9):1556-1564.
[43] HERGENREIDER E, HEYDT S, TRÉGUER K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14(3):249-256.
[44] JUNG JH, FU X, YANG PC. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases. Circ Res. 2017;120(2):407-417.
[45] SONG J, CHEN X, WANG M, et al. Cardiac endothelial cell-derived exosomes induce specific regulatory B cells. Sci Rep. 2014;4:7583.
[46] ELMING MB, HAMMER-HANSEN S, VOGES I, et al. Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure-DANISH-MRI. Am Heart J. 2020;221:165-176.
[47] XU MY, YE ZS, SONG XT, et al. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther. 2019;10(1):194.
[48] BANG C, BATKAI S, DANGWAL S, et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124(5):2136-2146.
[49] LYU L, WANG H, LI B, et al. A critical role of cardiac fibroblast-derived exosomes in activating renin angiotensin system in cardiomyocytes. J Mol Cell Cardiol. 2015;89(Pt B):268-279.
[50] ABRIAL M, DA SILVA CC, PILLOT B, et al. Cardiac fibroblasts protect cardiomyocytes against lethal ischemia-reperfusion injury. J Mol Cell Cardiol. 2014;68:56-65.
[51] LUO H, LI X, LI T, et al. microRNA-423-3p exosomes derived from cardiac fibroblasts mediates the cardioprotective effects of ischaemic post-conditioning. Cardiovasc Res. 2019;115(7):1189-1204.
[52] LI X, YANG Z, NIE W, et al. Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways. Cell Death Dis. 2019;10(10):691.
[53] XIAO J, PAN Y, LI XH, et al. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016;7(6):e2277.
[54] BARILE L, CERVIO E, LIONETTI V, et al. Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A. Cardiovasc Res. 2018;114(7):992-1005.
[55] ZHANG X, WANG X, ZHU H, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 2010;49(5):841-850.
[56] CHEN L, WANG Y, PAN Y, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem Biophys Res Commun. 2013;431(3):566-571.
[57] LI S, JIANG J, YANG Z, et al. Cardiac progenitor cell‑derived exosomes promote H9C2 cell growth via Akt/mTOR activation. Int J Mol Med. 2018;42(3):1517-1525.
[58] BEI Y, DAS S, RODOSTHENOUS RS, et al. Extracellular Vesicles in Cardiovascular Theranostics. Theranostics. 2017;7(17):4168-4182.
[59] YIN K, WANG S, ZHAO RC. Exosomes from mesenchymal stem/stromal cells: a new therapeutic paradigm. Biomark Res. 2019;7:8.
[60] LUTHER KM, HAAR L, MCGUINNESS M, et al. Exosomal miR-21a-5p mediates cardioprotection by mesenchymal stem cells. J Mol Cell Cardiol. 2018;119:125-137.
[61] ZHAO Y, SUN X, CAO W, et al. Exosomes derived from human umbilical cord mesenchymal stem cells relieve acute myocardial ischemic injury. Stem Cells Int. 2015;2015:761643.
[62] MA J, ZHAO Y, SUN L, et al. Exosomes derived from akt-modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet-derived growth factor D. Stem Cells Transl Med. 2017;6(1):51-59.
[63] WANG C, ZHANG C, LIU L, et al. Macrophage-Derived mir-155-containing exosomes suppress fibroblast proliferation and promote fibroblast inflammation during cardiac injury. Mol Ther. 2017;25(1):192-204.
[64] CUI X, HE Z, LIANG Z, et al. Exosomes from adipose-derived mesenchymal stem cells protect the myocardium against ischemia/reperfusion injury through Wnt/β-catenin signaling pathway. J Cardiovasc Pharmacol. 2017;70(4):225-231.
[65] CHEN Q, LIU Y, DING X, et al. Bone marrow mesenchymal stem cell-secreted exosomes carrying microRNA-125b protect against myocardial ischemia reperfusion injury via targeting SIRT7. Mol Cell Biochem. 2020;465(1-2):103-114.
[66] SUN XH, WANG X, ZHANG Y, et al. Exosomes of bone-marrow stromal cells inhibit cardiomyocyte apoptosis under ischemic and hypoxic conditions via miR-486-5p targeting the PTEN/PI3K/AKT signaling pathway. Thromb Res. 2019;177:23-32.
[67] ZHU LP, TIAN T, WANG JY, et al. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163-6177.
[68] TENG X, CHEN L, CHEN W, et al. Mesenchymal Stem Cell-Derived Exosomes Improve the Microenvironment of Infarcted Myocardium Contributing to Angiogenesis and Anti-Inflammation. Cell Physiol Biochem. 2015;37(6):2415-2424.
[69] MARINARO F, GÓMEZ-SERRANO M, JORGE I, et al. Unraveling the molecular signature of extracellular vesicles from endometrial-derived mesenchymal stem cells: potential modulatory effects and therapeutic applications. Front Bioeng Biotechnol. 2019;7:431.
[70] JIANG Z, HU X, YU H, et al. Human endometrial stem cells confer enhanced myocardial salvage and regeneration by paracrine mechanisms. J Cell Mol Med. 2013;17(10):1247-1260.
[71] WEI Z, QIAO S, ZHAO J, et al. miRNA-181a over-expression in mesenchymal stem cell-derived exosomes influenced inflammatory response after myocardial ischemia-reperfusion injury. Life Sci. 2019; 232:116632.
[72] WANG K, JIANG Z, WEBSTER KA, et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal microRNA-21. Stem Cells Transl Med. 2017;6(1):209-222.
|